This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn.
Study design
A prospective, multicentre case-series study in the United States. Patients were recruited at five different centres.
Analysis of effectiveness
The analysis of the clinical study was based on treatment completers only. The primary health outcome used was the outcome of the pregnancy (in terms of birth weight and proportion of major congenital anomalies). Within one week of enrolment, the women were called at home and a 30-minute telephone interview was conducted by trained project staff. In addition, a thorough review of all office and clinic records and maternal and infant hospital records was conducted using a standard data-collection instrument. PC women with type 1 diabetes were more likely to be white, were more highly educated and had a higher family income than PN women with type 1 diabetes. PC women were significantly earlier in pregnancy than PN women and were significantly more likely to experience spontaneous abortions than were PN women.
Effectiveness results
Mean birth weights were significantly higher for infants of PC women than for infants of PN women: 3,584g (+/-166g) versus 3,167g (+/-102g), p<0.05. Infants of PC mothers were significantly less likely to require intravenous glucose after delivery than were infants of PN women (5% versus 37%, p<0.05). Major congenital anomalies were diagnosed in 10 infants (14%) of PN women but in only 1 infant of a PC woman (5%).
Clinical conclusions
This study demonstrated that PC women with type 1 diabetes are seen earlier in gestation and have better glycosylated haemoglobin levels at their first prenatal visit, and throughout pregnancy, than do PN women with type 1 diabetes. This suggests that when implemented in community practice, preconception care achieves its major intended goals of better glycemic control during fetal organogenesis to reduce the risk of major congenital malformations and better timing of pregnancy so that it is more likely to be planned and wanted.
Measure of benefits used in the economic analysis
No summary benefit measure was identified in the economic analysis and only separate outcomes were reported (costconsequences analysis).
Direct costs
Quantities and costs were analysed separately. The cost of physician visits and of a hospital inpatient day were those included in the analysis. The estimation of quantities was based on actual data. Price information was taken from other studies.
